- Home
- CLST vs DXR Comparison
CLST vs DXR Comparison
Compare CLST & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- DXR
- Stock Information
- Founded
- CLST 1922
- DXR 1970
- Country
- CLST United States
- DXR United States
- Employees
- CLST N/A
- DXR N/A
- Industry
- CLST
- DXR Medical/Dental Instruments
- Sector
- CLST
- DXR Health Care
- Exchange
- CLST Nasdaq
- DXR Nasdaq
- Market Cap
- CLST 51.8M
- DXR 46.9M
- IPO Year
- CLST N/A
- DXR N/A
- Fundamental
- Price
- CLST $12.55
- DXR $11.03
- Analyst Decision
- CLST
- DXR Strong Buy
- Analyst Count
- CLST 0
- DXR 1
- Target Price
- CLST N/A
- DXR $25.00
- AVG Volume (30 Days)
- CLST 2.2K
- DXR 77.6K
- Earning Date
- CLST 07-24-2025
- DXR 01-01-0001
- Dividend Yield
- CLST N/A
- DXR N/A
- EPS Growth
- CLST N/A
- DXR 86.16
- EPS
- CLST 0.58
- DXR 0.11
- Revenue
- CLST $11,354,000.00
- DXR $119,714.00
- Revenue This Year
- CLST N/A
- DXR N/A
- Revenue Next Year
- CLST N/A
- DXR N/A
- P/E Ratio
- CLST $21.68
- DXR $104.69
- Revenue Growth
- CLST 164.54
- DXR N/A
- 52 Week Low
- CLST $10.67
- DXR $6.55
- 52 Week High
- CLST $14.23
- DXR $11.38
- Technical
- Relative Strength Index (RSI)
- CLST 57.28
- DXR 63.83
- Support Level
- CLST $12.50
- DXR $9.53
- Resistance Level
- CLST $12.59
- DXR $11.38
- Average True Range (ATR)
- CLST 0.05
- DXR 0.74
- MACD
- CLST 0.01
- DXR 0.11
- Stochastic Oscillator
- CLST 73.06
- DXR 84.65
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.